Clinical Trial: A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

U.S., Dec. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07300839) titled 'A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age' on Nov. 27.

Brief Summary: This study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health problems, compared to a group that receives a vaccine that doesn't contain an ingredient to protect against COVID-19 (placebo).

Study Start Date: Dec. 10

Study Type: INTERVENTIONAL

Condition: COVID-19 SARS-COV-2 Infection

Intervention: BIOLOGICAL: BNT162b2 Vaccine

Single dose

BIOLOGICAL: Placebo

Single dose

Recruitment Status: RECRUITING

Sponsor: BioNTech SE

Disclaimer: Curated by HT S...